Cargando…

Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis

BACKGROUND: Liraglutide is glucagon-like peptide-1 receptor agonist for treating patients with type 2 diabetes mellitus. Our previous studies have demonstrated that liraglutide protects cardiac function through improving endothelial function in patients with acute myocardial infarction undergoing pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Shun-Ying, Zhang, Ying, Zhu, Ping-Jun, Zhou, Hao, Chen, Yun-Dai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329734/
https://www.ncbi.nlm.nih.gov/pubmed/28270843
http://dx.doi.org/10.11909/j.issn.1671-5411.2017.01.008
_version_ 1782511114279452672
author Hu, Shun-Ying
Zhang, Ying
Zhu, Ping-Jun
Zhou, Hao
Chen, Yun-Dai
author_facet Hu, Shun-Ying
Zhang, Ying
Zhu, Ping-Jun
Zhou, Hao
Chen, Yun-Dai
author_sort Hu, Shun-Ying
collection PubMed
description BACKGROUND: Liraglutide is glucagon-like peptide-1 receptor agonist for treating patients with type 2 diabetes mellitus. Our previous studies have demonstrated that liraglutide protects cardiac function through improving endothelial function in patients with acute myocardial infarction undergoing percutaneous coronary intervention. The present study will investigate whether liraglutide can perform direct protective effects on cardiomyocytes against reperfusion injury. METHODS: In vitro experiments were performed using H9C2 cells and neonatal rat ventricular cadiomyocytes undergoing simulative hypoxia/reoxygenation (H/R) induction. Cardiomyocytes apoptosis was detected by fluorescence TUNEL. Mitochondrial membrane potential (ΔΨm) and intracellular reactive oxygen species (ROS) was assessed by JC-1 and DHE, respectively. Fura-2/AM was used to measure intracellular Ca(2+) concentration and calcium transient. Immunofluorescence staining was used to assess the expression level of sarcoplasmic reticulum Ca(2+)-ATPase (SERCA2a). In vivo experiments, myocardial apoptosis and expression of SERCA2a were detected by colorimetric TUNEL and by immunofluorescence staining, respectively. RESULTS: In vitro liraglutide inhibited cardiomyotes apoptosis against H/R. ΔΨm of cardiomyocytes was higher in liraglutide group than H/R group. H/R increased ROS production in H9C2 cells which was attenuated by liraglutide. Liraglutide significantly lowered Ca(2+) overload and improved calcium transient compared with H/R group. Immunofluorescence staining results showed liraglutide promoted SERCA2a expression which was decreased in H/R group. In ischemia/reperfusion rat hearts, apoptosis was significantly attenuated and SERCA2a expression was increased by liraglutide compared with H/R group. CONCLUSIONS: Liraglutide can directly protect cardiomyocytes against reperfusion injury which is possibly through modulation of intracellular calcium homeostasis.
format Online
Article
Text
id pubmed-5329734
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Science Press
record_format MEDLINE/PubMed
spelling pubmed-53297342017-03-07 Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis Hu, Shun-Ying Zhang, Ying Zhu, Ping-Jun Zhou, Hao Chen, Yun-Dai J Geriatr Cardiol Research Article BACKGROUND: Liraglutide is glucagon-like peptide-1 receptor agonist for treating patients with type 2 diabetes mellitus. Our previous studies have demonstrated that liraglutide protects cardiac function through improving endothelial function in patients with acute myocardial infarction undergoing percutaneous coronary intervention. The present study will investigate whether liraglutide can perform direct protective effects on cardiomyocytes against reperfusion injury. METHODS: In vitro experiments were performed using H9C2 cells and neonatal rat ventricular cadiomyocytes undergoing simulative hypoxia/reoxygenation (H/R) induction. Cardiomyocytes apoptosis was detected by fluorescence TUNEL. Mitochondrial membrane potential (ΔΨm) and intracellular reactive oxygen species (ROS) was assessed by JC-1 and DHE, respectively. Fura-2/AM was used to measure intracellular Ca(2+) concentration and calcium transient. Immunofluorescence staining was used to assess the expression level of sarcoplasmic reticulum Ca(2+)-ATPase (SERCA2a). In vivo experiments, myocardial apoptosis and expression of SERCA2a were detected by colorimetric TUNEL and by immunofluorescence staining, respectively. RESULTS: In vitro liraglutide inhibited cardiomyotes apoptosis against H/R. ΔΨm of cardiomyocytes was higher in liraglutide group than H/R group. H/R increased ROS production in H9C2 cells which was attenuated by liraglutide. Liraglutide significantly lowered Ca(2+) overload and improved calcium transient compared with H/R group. Immunofluorescence staining results showed liraglutide promoted SERCA2a expression which was decreased in H/R group. In ischemia/reperfusion rat hearts, apoptosis was significantly attenuated and SERCA2a expression was increased by liraglutide compared with H/R group. CONCLUSIONS: Liraglutide can directly protect cardiomyocytes against reperfusion injury which is possibly through modulation of intracellular calcium homeostasis. Science Press 2017-01 /pmc/articles/PMC5329734/ /pubmed/28270843 http://dx.doi.org/10.11909/j.issn.1671-5411.2017.01.008 Text en Institute of Geriatric Cardiology http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission.
spellingShingle Research Article
Hu, Shun-Ying
Zhang, Ying
Zhu, Ping-Jun
Zhou, Hao
Chen, Yun-Dai
Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis
title Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis
title_full Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis
title_fullStr Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis
title_full_unstemmed Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis
title_short Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis
title_sort liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329734/
https://www.ncbi.nlm.nih.gov/pubmed/28270843
http://dx.doi.org/10.11909/j.issn.1671-5411.2017.01.008
work_keys_str_mv AT hushunying liraglutidedirectlyprotectscardiomyocytesagainstreperfusioninjurypossiblyviamodulationofintracellularcalciumhomeostasis
AT zhangying liraglutidedirectlyprotectscardiomyocytesagainstreperfusioninjurypossiblyviamodulationofintracellularcalciumhomeostasis
AT zhupingjun liraglutidedirectlyprotectscardiomyocytesagainstreperfusioninjurypossiblyviamodulationofintracellularcalciumhomeostasis
AT zhouhao liraglutidedirectlyprotectscardiomyocytesagainstreperfusioninjurypossiblyviamodulationofintracellularcalciumhomeostasis
AT chenyundai liraglutidedirectlyprotectscardiomyocytesagainstreperfusioninjurypossiblyviamodulationofintracellularcalciumhomeostasis